Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert Klupacs Insider Profile
4 Followers
Robert Klupacs, Director at Bio-Gene Technology Ltd., holds 3.96M shares in Bio-Gene Technology Ltd. (Ticker: AU:BGT), holds 390.98K shares in Opthea Limited (Ticker: CKDXF). Most recently, Robert Klupacs Bought ― shares of Bio-Gene Technology Ltd. on Jun 16, 2022 for an estimated value of 3.61K.
Robert Klupacs Bio-Gene Technology Ltd. (BGT)Director
Bio-Gene Technology Ltd. (BGT)
Director
Ranked #13,873 out of 99,797 Corporate Insiders
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
+26.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert Klupacs holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 01, 2021 - Mar 01, 2022
Return:+134.40%
The most profitable trade made by Robert Klupacs
Robert Klupacs's Trading History
Bio-Gene Technology Ltd.
Jun 16, 2022
Director
Informative Buy
3.61K
AU$154.29K
Opthea Limited
Nov 21, 2012
Managing Director & Chief Executive Officer
Uninformative Buy
―
$172.03K
List of latest transactions for each holding click on a transaction to see Robert Klupacs's performance on stock
You May Also Like
Robert Klupacs insider profile FAQ
What is the percentage of profitable transactions made by Robert Klupacs?
The percentage of profitable transactions made by Robert Klupacs is 60%.
What is the average return per transaction made by Robert Klupacs?
The average return per transaction made by Robert Klupacs is 26.50%.
What stocks does Robert Klupacs hold?
Robert Klupacs holds: AU:BGT, CKDXF stocks.
What was Robert Klupacs’s latest transaction?
Robert Klupacs latest transaction was an Informative Buy of AU$3.61K.
What was Robert Klupacs's most profitable transaction?
Robert Klupacs’s most profitable transaction was an Informative Buy of AU:BGT stock on March 1, 2021. The return on the trade was 134.40%.
What is Robert Klupacs's role in Bio-Gene Technology Ltd.?
Robert Klupacs's role in Bio-Gene Technology Ltd. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.